Estimating individual risk for lung cancer

Seminars in Respiratory and Critical Care Medicine

Volumn 32, Issue 1, 2011, Pages 3-9

  Etzel, Carol J ^a   Bach, Peter B ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

accuracy; chemoprevention; clinical utility; discriminatory power; Risk models; screening

Indexed keywords

ASBESTOS; BRCA1 PROTEIN; TOBACCO SMOKE;

ARTICLE; BACH MODEL; BLOOD SAMPLING; BREAST CANCER RISK ASSESSMENT TOOL; CALIBRATION; CANCER DIAGNOSIS; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL ASSESSMENT TOOL; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIETARY INTAKE; DNA EXTRACTION; ENVIRONMENTAL EXPOSURE; FAMILY HISTORY; FRUIT; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; LIVERPOOL LUNG PROJECT MODEL; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; LUNG EMPHYSEMA; MODEL; MORBIDITY; MORTALITY; OCCUPATIONAL EXPOSURE; ONCOGENE; PNEUMONIA; POPULATION BASED CASE CONTROL STUDY; PREDICTION MODEL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SPITZ MODEL; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; VEGETABLE;

HUMANS; LUNG NEOPLASMS; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SMOKING;

EID: 79954575084     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0031-1272864     Document Type: Article

References (43)

1. Risch H A., Howe G R., Jain M, Burch J D., Holowaty E J., Miller A B. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol 1993 138 5 281-293 (Pubitemid 23263599)
2. American Cancer Society. Cancer Facts and Figures 2010. Atlanta, GA American Cancer Society 2010
3. Amos C I., Xu W, Spitz M R. Is there a genetic basis for lung cancer susceptibility? Recent Results Cancer Res 1999 151 3-12
4. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000 321 7257 323-329 (Pubitemid 30496873)
5. Gail M H., Brinton L A., Byar D P. et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989 81 24 1879-1886 (Pubitemid 20026073)
6. Tyrer J, Duffy S W., Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004 23 7 1111-1130 (Pubitemid 38477070)
7. Tice J A., Cummings S R., Ziv E, Kerlikowske K. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 2005 94 2 115-122 (Pubitemid 41547108)
8. Imperiale T F., Wagner D R., Lin C Y., Larkin G N., Rogge J D., Ransohoff D F. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000 343 3 169-174 (Pubitemid 30489213)
9. Selvachandran S N., Hodder R J., Ballal M S., Jones P, Cade D. Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet 2002 360 9329 278-283 (Pubitemid 34874719)
10. Fears T R., Guerry D IV, Pfeiffer R M. et al. Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol 2006 24 22 3590-3596 (Pubitemid 46630531)
11. Cho E, Rosner B A., Feskanich D, Colditz G A. Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 2005 23 12 2669-2675 (Pubitemid 46179456)
12. Hartge P, Whittemore A S., Itnyre J, McGowan L, Cramer D, The Collaborative Ovarian Cancer Group. Rates and risks of ovarian cancer in subgroups of white women in the United States. Obstet Gynecol 1994 84 5 760-764 (Pubitemid 24329840)
13. Eastham J A., May R, Robertson J L., Sartor O, Kattan M W. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL. Urology 1999 54 4 709-713 (Pubitemid 29449435)
14. Wu X, Lin J, Grossman H B. et al. Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol 2007 25 31 4974-4981 (Pubitemid 350220430)
15. Colditz G A., Atwood K A., Emmons K et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control 2000 11 6 477-488 (Pubitemid 30342837)
16. Bach P B., Kattan M W., Thornquist M D. et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003 95 6 470-478 (Pubitemid 36432421)
17. Spitz M R., Hong W K., Amos C I. et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007 99 9 715-726 (Pubitemid 47073532)
18. Cassidy A, Duffy S W., Myles J P., Liloglou T, Field J K. Lung cancer risk prediction: a tool for early detection. Int J Cancer 2007 120 1 1-6 (Pubitemid 44901910)
19. Woloshin S, Schwartz L M., Welch H G. The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst 2008 100 12 845-853 (Pubitemid 351881950)
20. Chen J, Pee D, Ayyagari R et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006 98 17 1215-1226 (Pubitemid 44390992)
21. Cook N R. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 2008 54 1 17-23 (Pubitemid 351182592)
22. Harrell F E. Jr, Lee K L., Mark D B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996 15 4 361-387 (Pubitemid 26072233)
23. Cronin K A., Gail M H., Zou Z, Bach P B., Virtamo J, Albanes D. Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst 2006 98 9 637-640 (Pubitemid 43904847)
24. D'Amelio A M. Jr, Cassidy A, Asomaning K et al. Comparison of discriminatory power and accuracy of three lung cancer risk models. Br J Cancer 2010 103 3 423-429
25. Marshall R J. Displaying clinical data relationships using scaled rectangle diagrams. Stat Med 2001 20 7 1077-1088
26. Marshall R J. Scaled rectangle diagrams can be used to visualize clinical and epidemiological data. J Clin Epidemiol 2005 58 10 974-981 (Pubitemid 41316440)
27. Marshall R J. Cardiovascular risk can be represented by scaled rectangle diagrams. J Clin Epidemiol 2009 62 9 998-1000
28. Abidoye O, Ferguson M K., Salgia R. Lung carcinoma in African Americans. Nat Clin Pract Oncol 2007 4 2 118-129 (Pubitemid 46189540)
29. Etzel C J., Kachroo S, Liu M et al. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res (Phila) 2008 1 4 255-265
30. Bain C, Feskanich D, Speizer F E. et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 2004 96 11 826-834 (Pubitemid 38807603)
31. Bach P B. Lung cancer screening. J Natl Compr Canc Netw 2008 6 3 271-275 (Pubitemid 351488821)
32. Bach P B., Jett J R., Pastorino U, Tockman M S., Swensen S J., Begg C B. Computed tomography screening and lung cancer outcomes. JAMA 2007 297 9 953-961 (Pubitemid 46376749)
33. Infante M, Cavuto S, Lutman F R. et al, DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009 180 5 445-453
34. van Iersel C A., de Koning H J., Draisma G et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007 120 4 868-874 (Pubitemid 46175408)
35. Janssens ACJW, Moonesinghe R, Yang Q, Steyerberg E W., van Duijn C M., Khoury M J. The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med 2007 9 8 528-535 (Pubitemid 47282041)
36. Alberg A J., Samet J M. Epidemiology of lung cancer. In: Sadler M J. Callaero B Strain J J. eds. Encyclopedia of Human Nutrition. London, England Academic 1998 235-248
37. Männistö S, Smith-Warner S A., Spiegelman D et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 2004 13 1 40-48 (Pubitemid 38116619)
38. Gail M H. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst 2008 100 14 1037-1041 (Pubitemid 352019794)
39. Gail M H. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. J Natl Cancer Inst 2009 101 13 959-963
40. Spitz M R., Amos C I., D'Amelio A Jr, Dong Q, Etzel C. Re: discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst 2009 101 24 1731-1732, author reply 1732
41. Jakobsdottir J, Gorin M B., Conley Y P., Ferrell R E., Weeks D E. Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet 2009 5 2 e1000337
42. Janssens ACJW, Aulchenko Y S., Elefante S, Borsboom GJJM, Steyerberg E W., van Duijn C M. Predictive testing for complex diseases using multiple genes: fact or fiction? Genet Med 2006 8 7 395-400 (Pubitemid 44289001)
43. Spitz M R., Etzel C J., Dong Q et al. An expanded risk prediction model of lung cancer. Can Prev Res 2008 1 4 250-254